Cargando…

Advanced lung adenocarcinomas with ROS1-rearrangement frequently show hepatoid cell

Defining distinctive histologic characteristics of ROS1-rearranged non-small-cell lung carcinomas (NSCLCs) may help identify cases that merit molecular testing. However, the majority of previous reports have focused on surgical specimens but only limited studies assessed histomorphology of advanced...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Jing, Zheng, Jing, Kong, Mei, Zhou, Jianya, Ding, Wei, Zhou, Jianying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342043/ https://www.ncbi.nlm.nih.gov/pubmed/27708233 http://dx.doi.org/10.18632/oncotarget.12364

Ejemplares similares

A Prediction Model for ROS1-Rearranged Lung Adenocarcinomas based on Histologic Features
por: Zhou, Jianya, et al.
Publicado: (2016)

Poor response to gefitinib in lung adenocarcinoma with concomitant epidermal growth factor receptor mutation and anaplastic lymphoma kinase rearrangement
por: Zhou, Jianya, et al.
Publicado: (2015)

Significant Radiologic Response of Pancreatic Metastasis After Targeted Therapy of Ceritinib (LDK378) for ALK-Rearranged Lung Adenocarcinoma Presenting With Hyperglycemia
por: Zheng, Jing, et al.
Publicado: (2017)

Hepatoid adenocarcinoma of the lung
por: Cavalcante, Lívia Barreira, et al.
Publicado: (2013)

Hepatoid Adenocarcinoma of the Lung
por: Li, Meihui, et al.
Publicado: (2021)

Hepatoid adenocarcinoma of the lung accompanied with multiple systemic metastases
por: Chen, Jing-Xian, et al.
Publicado: (2021)

Hepatoid Adenocarcinoma Of The Lung Metastasizing To The Gingiva
por: Wang, Chunhua, et al.
Publicado: (2019)

Hepatoid adenocarcinoma of the gallbladder
por: Ellouze , Sameh, et al.
Publicado: (2011)

Hepatoid Adenocarcinoma of the Urachus
por: Gallego, Daniel Fernando, et al.
Publicado: (2016)

Primary Hepatoid Adenocarcinoma of the Lung: A Systematic Literature Review
por: Chen, Zhitao, et al.
Publicado: (2022)

Hepatoid adenocarcinoma of the lung: Presenting mediastinal metastasis without transfer to the liver
por: CHE, YI-QUN, et al.
Publicado: (2014)

Primary hepatoid adenocarcinoma of the orbit
por: Alsberge, Joseph B., et al.
Publicado: (2016)

Hepatoid Adenocarcinoma Presenting as Pancreatitis
por: Chaudhari, Rahul, et al.
Publicado: (2020)

Hepatoid Adenocarcinoma of the Pancreatic Head
por: Holt, Alex, et al.
Publicado: (2022)

Hepatoid adenocarcinoma of the lung mimicking metastatic hepatocellular carcinoma
por: Miyama, Yu, et al.
Publicado: (2020)

Hepatoid Adenocarcinoma of the Lung: A Rare Form of Lung Cancer
por: Laraqui Houssein, Yasmine, et al.
Publicado: (2022)

Accurate and Economical Detection of ALK Positive Lung Adenocarcinoma with Semiquantitative Immunohistochemical Screening
por: Zhou, Jianya, et al.
Publicado: (2014)

Screening of ROS1 Rearrangements in Lung Adenocarcinoma by Immunohistochemistry and Comparison with ALK Rearrangements
por: Cha, Yoon Jin, et al.
Publicado: (2014)

Hepatoid Adenocarcinoma of the Stomach: Current Perspectives and New Developments
por: Xia, Ruolan, et al.
Publicado: (2021)

Hepatoid Adenocarcinoma of the Duodenum: An Unusual Location
por: Ogbonna, Onyekachi Henry, et al.
Publicado: (2016)

Hepatoid adenocarcinoma of the stomach: CT findings
por: Yang, Qian, et al.
Publicado: (2023)

Multiple cerebral infarctions in ROS1‐rearranged lung adenocarcinoma
por: Ikushima, Hiroaki, et al.
Publicado: (2021)

Integrative analysis reveals a clinicogenomic landscape associated with liver metastasis and poor prognosis in hepatoid adenocarcinoma of the stomach
por: Jiang, Junjie, et al.
Publicado: (2022)

Loss of LIMCH1 predicts poor prognosis in patients with surgically resected Lung Adenocarcinoma: A study based on Immunohistochemical Analysis and Bioinformatics
por: Cao, He, et al.
Publicado: (2021)

Clinicopathological characteristics and outcomes of ROS1-rearranged patients with lung adenocarcinoma without EGFR, KRAS mutations and ALK rearrangements
por: Wu, Shafei, et al.
Publicado: (2015)

Hepatoid adenocarcinoma of the gallbladder with production of alpha-fetoprotein
por: Lee, Jae Hoon, et al.
Publicado: (2011)

Pulmonary hepatoid adenocarcinoma: report of a case
por: Motooka, Yamato, et al.
Publicado: (2016)

Clinicopathological and Prognostic Characteristics of Hepatoid Adenocarcinoma of the Stomach
por: Yang, Jinlin, et al.
Publicado: (2014)

Treatment of gastric hepatoid adenocarcinoma with pembrolizumab and bevacizumab combination chemotherapy: A case report
por: Liu, Mei, et al.
Publicado: (2022)

Detection of lung adenocarcinoma with ROS1 rearrangement by IHC, FISH, and RT-PCR and analysis of its clinicopathologic features
por: Cao, Bing, et al.
Publicado: (2015)

Primary mediastinal hepatoid adenocarcinoma: case description of a rare condition
por: Jin, Mengni, et al.
Publicado: (2023)

Computed Tomography Features and Clinical Prognostic Characteristics of Hepatoid Adenocarcinoma of the Stomach
por: Huang, Wen-peng, et al.
Publicado: (2021)

Hepatoid adenocarcinoma of the duodenal papilla with hepatic metastases: A case report and literature review
por: Han, Lu, et al.
Publicado: (2022)

Hepatoid adenocarcinoma of the stomach: a unique subgroup with distinct clinicopathological and molecular features
por: Wang, Yakun, et al.
Publicado: (2019)

Hepatoid adenocarcinoma of the stomach: Thirteen case reports and review of literature
por: Zhang, Zheng-Rong, et al.
Publicado: (2020)

CT features and disease spread patterns in ROS1-rearranged lung adenocarcinomas: comparison with those of EGFR-mutant or ALK-rearranged lung adenocarcinomas
por: Woo, Jung Han, et al.
Publicado: (2020)

Hepatoid Adenocarcinoma of the Lung Responsive to Frontline Combination Chemotherapy With Immunotherapy: Case Report
por: Lagos, Galina G., et al.
Publicado: (2020)

Hepatoid Adenocarcinoma of the Lung: A Systematic Review of the Literature From 1981 to 2020
por: Hou, Zan, et al.
Publicado: (2021)

Alpha-Fetoprotein-Producing Lung Hepatoid Adenocarcinoma with Brain Metastasis Treated with S-1
por: Muroyama, Yuki, et al.
Publicado: (2020)

Hepatoid adenocarcinoma of the lung: An analysis of the Surveillance, Epidemiology, and End Results (SEER) database
por: Lei, Lei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ndrclpc904o1bm2puft56780io